Study to Evaluate Safety and Efficacy of UB-421 Antibody in HIV-1 Infected Adults

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions

HIV-1 Infection in Adults

Interventions

DRUG

Antibody UB-421

UB-421 is administered by intravenous infusion

Trial Locations (2)

Taipei Veterans General Hospital (TVGH), Taipei

Kaohsiung Veterans General Hospital (KVGH), Kaohsiung City

All Listed Sponsors

collaborator

Taipei Veterans General Hospital, Taiwan

OTHER_GOV

collaborator

Kaohsiung Veterans General Hospital.

OTHER

collaborator

UBI Asia in Taiwan

UNKNOWN

lead

United Biomedical

INDUSTRY

NCT01668043 - Study to Evaluate Safety and Efficacy of UB-421 Antibody in HIV-1 Infected Adults | Biotech Hunter | Biotech Hunter